NCT02315508 - Evaluating Possible Improvement in Tinnitus Severity After 28 Days Dosing of the Study Drug AUT00063 Compared to Placebo | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Tinnitus, Subjective

Interventions

DRUG

AUT00063

800 mg orally, once a day, for 4 weeks

DRUG

Placebo

orally, once a day, for 4 weeks

Trial Locations (18)

B15 2WB

Birmingham University Hospital, Birmingham

BD9 6RJ

Bradford Teaching Hospital, Bradford

BS2 8HW

Bristol Royal Infirmary, Bristol

CB2 0QQ

Cambridge University Hospitals NHS Trust, Cambridge

GU16 7UJ

Frimley Health NHS Foundation Trust, Frimley

WC1E 6BT

University College London Hospital NHS Foundation Trust, London

M8 5RB

The Pennine Acute Hospitals NHS Trust, Manchester

NE7 7DN

Freeman Hospital, Newcastle

NR4 7UY

Norfolk and Norwich University Hospital Foundation Trust, Norwich

NG7 2UH

Nottingham University Hospitals NHS Trust, Nottingham

PL6 8DH

Derriford Plymouth NHS Trust, Plymouth

PO6 3LY

Portsmouth Hospitals NHS Trust, Portsmouth

M6 8HD

Salford Royal Hospital, Salford

S10 3BR, UK

Royal Hallamshire Hospital, Sheffield, Sheffield

SG1 4AB

Lister Hospital, Stevenage

ST4 6QG

University Hospital of North Staffordshire, Stoke-on-Trent

TF1 6TF

Shrewsbury and Telford Hospital NHS Trust, Telford

WN6 9EP

Wrightington Hospital, Wigan